Viewing Study NCT00215202


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2025-12-26 @ 2:49 AM
Study NCT ID: NCT00215202
Status: COMPLETED
Last Update Posted: 2018-05-17
First Post: 2005-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module